Vanda Pharmaceuticals, Inc. (VNDA)

7.51 +0.04 (+0.54%) USD  |  NASDAQ  |  Jan 20, 13:48
More

Vanda Pharmaceuticals Normalized Income (Quarterly)

Normalized Income (Quarterly) Chart

View Normalized Income (Quarterly) for VNDA.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Normalized Income (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Normalized Income (Quarterly) Range, Past 5 Years

View Normalized Income (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Normalized Income (Quarterly) Benchmarks

View Normalized Income (Quarterly) Benchmarks
Start Trial
Aldeyra Therapeutics, Inc. Upgrade
Eli Lilly & Co. Upgrade
ADMA Biologics, Inc. Upgrade
Axsome Therapeutics, Inc. Upgrade
AnaptysBio, Inc. Upgrade